« Back to Record
Citation APA

Andresen, N. K., Røssevold, A. H., Quaghebeur, C., Gilje, B., Boge, B., Gombos, A., Falk, R. S., Mathiesen, R. R., Julsrud, L., Garred, O., Russnes, H. G., Lereim, R. R., Chauhan, S. K., Lingjærde, O. C., Dunn, C., Naume, B., & Kyte, J. A. (2024). Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: A randomized phase 2b trial. Journal for ImmunoTherapy of Cancer, 12(1), e007990. doi:10.1136/jitc-2023-007990


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371282

Andresen, N. K., Røssevold, A. H., Quaghebeur, C., Gilje, B., Boge, B., Gombos, A., Falk, R. S., Mathiesen, R. R., Julsrud, L., Garred, O., Russnes, H. G., Lereim, R. R., Chauhan, S. K., Lingjærde, O. C., Dunn, C., Naume, B., & Kyte, J. A. (2024). Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: A randomized phase 2b trial. Journal for ImmunoTherapy of Cancer, 12(1), e007990. doi:10.1136/jitc-2023-007990